Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Essential Healthcare News.

Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
BRISBANE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated...

Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis...

The Plastic Surgery Channel Rebrands to MediaPSC to Reflect Broader Healthcare Expertise
The Plastic Surgery Channel, the premier video production company founded by leading plastic surgeons, today announced an exciting rebrand to MediaPSC. The name change reflects the company’s expanded services and expertise across the full spectrum...

Cybersecurity Is a Top Priority as Healthcare Software Investments Grow in 2025
Following a year of high-profile data breaches impacting millions of patients, healthcare organizations across the U.S. are doubling down on cybersecurity while ramping up tech investments. According to Software Advice’s latest Medical Tech Trends...

Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the addition of healthcare veteran Elizabeth Bierbower to its Board of Directors. "As we...

Perimeter Healthcare Bolsters Executive Leadership Team by Naming Jason D. Bailey as Chief Development Officer
ALPHARETTA, GA, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- Perimeter Healthcare, is pleased to announce the appointment of Jason D. Bailey as Chief Development Officer. Jason will be responsible for new acquisitions and driving strategic...

NextGen Healthcare Selected by Southwest Michigan Dermatology to Optimize Practice Management and Improve Patient Experience
NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, has been selected by Southwest Michigan Dermatology to streamline operations and support an enhanced patient experience. NextGen® Enterprise PM...

enGene to Present at the Jefferies Global Healthcare Conference
enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced that Ron Cooper, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference in New...

Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
DUBLIN, Ireland, May 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a...

Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
THE WOODLANDS, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference, taking place in New...

Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference
WALTHAM, Mass. and BOULDER, Colo., May 29, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced its presentation at...

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance
NEW YORK and MELBOURNE, Australia, May 29, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing novel combination therapies, today announced that the Phase 3 component of the RePOSA...

Apogee Therapeutics to Participate at the Jefferies Global Healthcare Conference
SAN FRANCISCO and BOSTON, May 29, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5,...

KalVista Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 8:45 a.m. ET. A live webcast of the presentation will...

AgelessRx Broadens GLP-1 Weight Care Options to Advance Longevity-First Healthcare
AgelessRx, a pioneer in longevity and telehealth solutions, is expanding its suite of GLP-1 offerings to better serve customers seeking sustainable, medically guided solutions. The updated offering includes access to Zepbound® via LillyDirect® and...

Dr. John Fortuna Announces Healthcare Grant Challenging Students to Redefine Aging through Innovation in Longevity and Regenerative Medicine
CLEVELAND, May 29, 2025 (GLOBE NEWSWIRE) -- The Dr. John Fortuna Grant, founded by Cleveland-based chiropractor and wellness advocate Dr. John Fortuna, is now accepting applications for the 2026 cycle. This nationwide academic grant invites...

Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically...

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno,...

Top Growth Driver In The Vestibular Neuronitis Treatment Market 2025: Rising Healthcare Expenditures Fueling Market
The Business Research Company’s Vestibular Neuronitis Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- The global market for Vestibular...

Replimune to Present at the 2025 Jefferies Global Healthcare Conference
WOBURN, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members of the Replimune management...